Page last updated: 2024-11-02

oxidopamine and Hemolysis

oxidopamine has been researched along with Hemolysis in 1 studies

Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).

Hemolysis: The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tiurenkov, IN1
Volotova, EV1
Kurkin, DV1
Bakulin, DA1
Logvinov, IO1
Antipova, TA1

Other Studies

1 other study available for oxidopamine and Hemolysis

ArticleYear
[Neuroprotective effect of neuroglutam under conditions of activated free radical oxidation].
    Eksperimental'naia i klinicheskaia farmakologiia, 2014, Volume: 77, Issue:8

    Topics: Animals; Brain Ischemia; Cell Line, Tumor; Erythrocytes; Free Radicals; Glutamic Acid; Hemolysis; Hu

2014